Prospect: information for the user
Fluconazole Aurovitas 50 mg hard capsules EFG
Fluconazole Aurovitas 100 mg hard capsules EFG
Fluconazole Aurovitas 150 mg hard capsules EFG
Fluconazole Aurovitas 200 mg hard capsules EFG
fluconazole
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
1.What is Fluconazole Aurovitas and what it is used for
2.What you need to know before starting to take Fluconazole Aurovitas
3.How to take Fluconazole Aurovitas
4.Possible adverse effects
5.Storage of Fluconazole Aurovitas
6.Contents of the pack and additional information
This medication is one of the medications in the group called "antifungals". The active ingredient is fluconazol.
This medication is used to treat infections caused by fungi, and it can also be used to prevent the appearance of candidiasis. The most common cause of fungal infections is a yeast calledCandida.
Adults
Your doctor may prescribe this medication to treat the following types of fungal infections:
Your doctor may also prescribe fluconazol for:
Children and adolescents (0 to17 years)
Your doctor may prescribe this medication to treat the following types of fungal infections:
Your doctor may also prescribe fluconazol for:
Do not take Fluconazol Aurovitas:
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication.
Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with fluconazole treatment. Stop taking fluconazole and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Speak with your doctor or pharmacist if the fungal infection does not improve, as an alternative antifungal treatment may be necessary.
Other medications and Fluconazol Aurovitas
Inform your doctor immediately if you are taking astemizole, terfenadine (an antihistamine for treating allergies), cisapride (used to treat stomach discomfort), pimozide (used to treat mental health conditions), quinidine (used to treat heart arrhythmias), or erythromycin (an antibiotic for treating infections), as these medications should not be taken with this medication (see section: “Do not take Fluconazol Aurovitas”).
There are some medications that may interact with this medication. Ensure that your doctor knows if you are taking any of the following medications, as it may be necessary to adjust the dose or monitor to ensure the medications continue to have the desired effect:
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
Taking Fluconazol Aurovitas with food, drinks, and alcohol
You can take the medication with or without food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before taking this medication.
If you are planning to become pregnant, it is recommended that you wait one week after a single dose of fluconazole before becoming pregnant.
For longer fluconazole treatment cycles, consult your doctor about the need to use suitable contraceptive methods during treatment, which should be maintained for one week after the last dose.
You should not take Fluconazol Aurovitas if you are pregnant, think you may be pregnant, or intend to become pregnant, or are breastfeeding, unless your doctor has told you to.If you become pregnant while taking this medication or within one week of the most recent dose, consult your doctor.
Fluconazole taken during the first or second trimester of pregnancy may increase the risk of spontaneous abortion. Fluconazole taken during the first trimester may increase the risk of congenital anomalies affecting the heart, bones, and/or muscles.
Cases of babies born with congenital anomalies affecting the skull, ears, and leg and elbow bones have been reported in women treated for three months or more with high doses (400-800 mg daily) of fluconazole for coccidioidomycosis. The relationship between fluconazole and these cases is unclear.
You can continue breastfeeding after taking a single dose of 150 mg of this medication.
You should not continue breastfeeding if you are taking repeated doses of this medication.
Driving and operating machinery
When driving or operating machinery, be aware that occasional dizziness or seizures may occur.
Fluconazol Aurovitas contains lactose monohydrate,a type of sugar.If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Fluconazol Aurovitas contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per hard capsule, which is essentially “sodium-free”.
Follow exactly the usage instructions of this medication as indicated by your doctor or pharmacist..
In case of doubt, consult your doctor or pharmacist again.
The capsules should be swallowed whole with the help of a glass of water. It is better to take your capsules at the same time every day.
Instructions for removing the capsule from the blister cavity:
Pressing the capsule cavity in the center may cause capsule deformation or breakage, as shown in Figure A. To avoid such damage to the capsule, press the capsule cavity at one end to remove it from the blister, as shown in Figure B.
Fig. AFig. B
Below, the recommended dose of this medication for different types of infections is indicated:
Adults
Infection | Dose |
To treat cryptococcal meningitis | 400 mg on the first day and subsequently 200 mg to 400 mg once a day for6 to8 weeks or longer if necessary. In some cases, the dose is increased to 800 mg |
To prevent the recurrence of cryptococcal meningitis | 200 mg once a day until your doctor tells you to |
To treat coccidioidomycosis | 200 mg to 400 mg once a day from 11 months to 24 months or longer if necessary. In some cases, the dose is increased to 800 mg |
To treat internal fungal infections caused byCandida | 800 mg on the first day and subsequently 400 mg once a day until your doctor tells you to |
To treat mucosal infections affecting the oral mucosa, pharynx, or associated with dental prostheses. | 200 mg to 400 mg on the first day, and then 100 mg to 200 mg once a day until your doctor tells you to |
To treat mucosal candidiasis – the dose depends on the location of the infection | 50 mg to 400 mg once a day for7 to30 days until your doctor tells you to |
To prevent the recurrence of mucosal infections affecting the oral mucosa and pharynx | 100 mg to 200 mg once a day, or 200 mg three times a week, as long as you are at risk of developing an infection |
To treat genital candidiasis | 150 mg as a single dose |
To reduce the recurrence of vaginal candidiasis | 150 mg every three days for a total of 3 doses (day 1, 4, and 7) and then once a week for 6 months as long as you are at risk of developing an infection |
To treat fungal skin or nail infections | Depending on the location of the infection, 50 mg once a day, 150 mg once a week,300 to400 mg once a week for1 to4 weeks (for athlete's foot, up to 6 weeks may be necessary, for nail infections, continue treatment until a healthy nail grows) |
To prevent the transmission of a Candida infection (if your immune system is weakened and does not function properly) | 200 mg to 400 mg once a day as long as you are at risk of developing an infection |
Use in children and adolescents
Adolescents aged12 to17 years
Follow the dose indicated by your doctor (adult or pediatric dosage)
Children up to 11 years
The maximum daily dose for children is 400 mg per day.
The dose will be based on the child's weight in kilograms.
Infection | Daily dose |
Mucosal candidiasis and pharyngeal infections caused byCandida– the dose and duration of treatment depend on the severity of the infection and its location. | 3mg per kg of body weight once a day (the first day may be 6mg per kg of body weight) |
Cryptococcal meningitis or internal fungal infections caused byCandida | 6 mg to 12mg per kg of body weight once a day |
To prevent the recurrence of cryptococcal meningitis | 6 mg per kg of body weight once a day |
To prevent a child from contracting a Candida infection (if their immune system does not function properly) | 3 mg to 12mg per kg of body weight once a day |
Use in children aged0 to4 weeks
Use in children aged3 to4 weeks:
The same dose as described in the table, but administered once every 2 days. The maximum dose is 12 mg per kg of body weight every 48 hours.
Use in children under 2 weeks of age:
The same dose as described in the table, but administered once every 3 days. The maximum dose is 12 mg per kg of body weight every 72 hours.
Older adults
The usual adult dose, unless you have kidney problems.
Patients with kidney problems
Your doctor may change your dose, depending on how well your kidneys are functioning.
If you take more Fluconazol Aurovitas than you should
Taking too many capsules at once may make you feel unwell.In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount taken. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
The symptoms of a possible overdose may include hearing, seeing, feeling, and thinking things that are not real (hallucinations and paranoid behavior). It may be appropriate to initiate symptomatic treatment (with supportive measures and gastric lavage if necessary).
If you forgot to take Fluconazol Aurovitas
Do not take a double dose to make up for the missed dose. If you forgot to take a dose, take it as soon as you remember. If there is little time left for the next dose, do not take the missed dose.
If you have any doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.Stop taking Fluconazol Aurovitas and seek medical attention immediately if you notice any of the following symptoms:
Some people developallergic reactionsalthough severe allergic reactions are rare.If you experience any of the following side effects, talk to your doctor or pharmacist. Thisincludes possible side effects not mentioned in this leaflet. If you suffer from any of the following side effects,inform your doctor or pharmacist immediately:
This medicine may affect your liver. Signs that indicate liver problems include:
If you experience any of these symptoms, stop taking this medicine andinform your doctor immediately
Other side effects:
Additionally, if you consider that any of the side effects you are experiencing are severe or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
Frequent side effects (may affect up to 1 in 10 people):
Less frequent side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1000 people):
Frequency not known but may occur (cannot be estimated from available data):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not mentioned in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of packaging and medications you no longer need. This will help protect the environment.
Composition of Fluconazol Aurovitas
The capsule composition is titanium dioxide (E171), sodium lauryl sulfate, and gelatin.
The printing ink contains shellac and yellow iron oxide (E172).
Appearance of the product and contents of the package
Fluconazol Aurovitas 50 mg hard capsules EFG
Hard gelatin capsules of white to off-white opaque color, size “4”, filled with white to off-white powder, and printed with the letter “FL” on the white to off-white opaque face and with the number “50” on the white to off-white opaque body with yellow ink.
Fluconazol Aurovitas 100 mg hard capsules EFG
Hard gelatin capsules of white to off-white opaque color, size “2”, filled with white to off-white powder, and printed with the letter “FL” on the white to off-white opaque face and with the number “100” on the white to off-white opaque body with yellow ink.
Fluconazol Aurovitas 150 mg hard capsules EFG
Hard gelatin capsules of white to off-white opaque color, size “1”, filled with white to off-white powder, and printed with the letter “FL” on the white to off-white opaque face and with the number “150” on the white to off-white opaque body with yellow ink.
Fluconazol Aurovitas 200 mg hard capsules EFG
Hard gelatin capsules of white to off-white opaque color, size “0”, filled with white to off-white powder, and printed with the letter “FL” on the white to off-white opaque face and with the number “200” on the white to off-white opaque body with yellow ink.
Fluconazol Aurovitas hard capsules are available in PVC/PVDC-Aluminium blisters.
Pack sizes of 1, 2, 3, 4, 6, 7, 10, 12, 14, 20, 28, 30, 42, 50, 60, 100, and 500 hard capsules.
Only some pack sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Aurovitas Spain, S.A.U.
Avda. De Burgos, 16-D
28036 Madrid
Spain.
Responsible manufacturer:
APL Swift Services (Malta) Ltd
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
or
Generis Farmaceutica, S.A.
Rua João de Deus, n. o 19, Venda Nova
2700-487, Amadora
Portugal
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Bélgica:Fluconazol AB 50 mg/100 mg/150 mg/200 mg harde capsules
Luxemburgo:Fluconazol AB 50 mg/100 mg/150 mg/200 mg harde capsules
Polonia:Fluconazole Aurovitas
Portugal:Fluconazol Ritisca
España:Fluconazol Aurovitas 50 mg/100 mg/150 mg/200 mg cápsulas duras EFG.
Last review date of this leaflet:February 2024
The detailed information of this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es)
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.